AMBUJACEMNSEAmbuja Cements Limited· Cement & Cement ProductsCriticalNegative
Announced Fri, 30 Jan, 2026 · 14:41 IST

MD Ajay Kapur retiring Jan 31, 2026; Q3 FY26 results announced

Ceo ResignedManagement Changes View source PDFExplain this filing

AMBUJACEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-4.9%Reaction day
₹536.00
prior close
₹516.05
announcement price
In-mkt
timing
Nifty 100market · index membership as recorded later (tracked since Jun 2026)-0.5%-4.5% vs market
Cement & Cement Products peers, median of 34sector-0.2%-4.7% vs sector

On the reaction day the stock moved 4.5 pts less than Nifty 100 and 4.7 pts less than its Cement & Cement Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.2
10m
-0.6
15m
-0.6
30m
-1.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-4.9-0.5-4.5-0.2-4.7
Next day
-4.7-1.4-3.3-1.0-3.7
2d
-1.5+1.1-2.6+0.4-1.9
3d
+0.0+1.4-1.4+2.5-2.5
4d
-0.7+0.9-1.5+1.8-2.4
5d
-1.5+1.1-2.6+0.7-2.1
1w
+0.5+2.0-1.6+2.9-2.4
15d
-4.2+0.8-4.9-2.0-2.2
1m
-8.2-1.8-6.5-5.1-3.1
2m
-25.1-12.1-13.0-21.1-4.0
3m
-17.2-4.3-12.8-4.9-12.2
UpDownMarket · Nifty 100Sector · Cement & Cement Products peers, median of 34Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ambuja Cements Board approved unaudited Q3 and 9M FY26 results. Consolidated Q3 revenue was Rs 10,180.52 crore versus Rs 8,498.10 crore a year ago. PAT fell to Rs 366.97 crore from Rs 2,662.97 crore, hit by exceptional items of Rs 258.17 crore. Standalone revenue was Rs 5,908.67 crore with PAT at Rs 203.99 crore. Managing Director Ajay Kapur will superannuate on January 31, 2026, and cease as Director and KMP. Two new Senior Management Personnel were appointed.

Likely market impact

MD transition may prompt succession focus; weaker Q3 profit on exceptional items could weigh on sentiment, though revenue growth stays steady.